ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for GENETIX BIOTHERAPEUTICS, INC. · Biotechnology and pharmaceutical company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $60,000.00 income · posted Jan 14, 2026

Lobbying activity 2

Medicare/Medicaid

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Health Issues

Issues and legislation related to access to gene therapies and treatment of rare diseases.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.